User:Dr Salfiyah Shameem/sandbox

What is a convalescent plasma therapy?

Blood being used from those who have fully recovered from an illness and being transfused to those who needs to recover from the disease, which historically has been used for the management of some wide range of infectious diseases.

This type of treatment has been popular in the initial management of the emerging viruses providing time and enabling the scientists to develop the vaccines and drugs in the meantime.

A pandemic, that has been inciting the constant fear and anxiety among the public worldwide, was first reported from the china in the ending month of 2019, was public in the media in the starting months of 2020, which has now inundated the whole world under its pinion; the covid-19 pandemic and yet to be undefeated by the scientists and researchers of the world.

The certitude that no specific treatment options has proven effective as yet against this virus, has further hyped the fear and anxiety among the humans.

The whole world was yet to overcome the first wave of the virus and was still hesitant to reinstate the work at the schools and the markets, when the second, yet drastically catastrophic wave of the virus emerged in the second largest populated country, India.

While the scientists and researchers were busy days and nights manufacturing the drugs and vaccines, the doctors and the paramedics were busy at the immunisation camps and urging the people to get vaccinated, even so, only 30 to 40 percent of the total population was ready to get vaccinated as there were rumours in the air that the vaccines are full of radical side effects.

Management options are few, supportive care being the mainstay of the treatment. Nevertheless, the specific treatment based on the antiviral drugs, (remdesivir) and IL-6 pathway inhibitors (tocilizumab) are still under the clinical trials.

The convalescent plasma therapy has shown some positive results in the first wave, however is seen to be of no use in the second wave due to the several rapid mutations of the virus.